EarningsQ2 2025 Earnings Report

Summit Therapeutics (SMMT) Q2 2025 Earnings Report

1 Followers

MX:SMMT Q2 2025 EPS Results

Actual EPS-$13.98

Consensus EPS-$1.67

Beat/MissMissed by -$12.30

One Year Ago EPS-$0.92

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2025

Date08/11/2025

TimeAfter Close

Conference CallMonday, August 11, 2025

MX:SMMT Upcoming Earnings

Summit Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-5.17 / -	-5.701	―
Jul 23, 2026	2026 (Q2)	-5.04 / -5.15	-13.977	63.16% (+8.83)
Apr 30, 2026	2026 (Q1)	-4.95 / -4.41	-1.655	-166.67% (-2.76)
Feb 23, 2026	2025 (Q4)	-1.42 / -5.33	-1.471	-262.50% (-3.86)
Oct 20, 2025	2025 (Q3)	-1.54 / -5.70	-1.471	-287.50% (-4.23)
Aug 11, 2025	2025 (Q2)	-1.67 / -13.98	-0.92	-1420.00% (-13.06)
May 01, 2025	2025 (Q1)	-1.71 / -1.66	-1.103	-50.00% (-0.55)
Feb 24, 2025	2024 (Q4)	-1.51 / -1.47	-0.92	-60.00% (-0.55)
Oct 30, 2024	2024 (Q3)	-1.23 / -1.47	-0.552	-166.67% (-0.92)
Aug 06, 2024	2024 (Q2)	-1.14 / -0.92	-0.386	-138.10% (-0.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed